Smart materials unlock better CBD absorption and delivery
Hydrophilic carriers for encapsulation of hydrophobic drug cannabidiol: Vaterite CaCO3 crystals and multilayer microgels made of sustainable polymers.
AI Summary
Researchers have developed innovative delivery systems for cannabidiol (CBD), a highly hydrophobic cannabinoid that's notoriously difficult to dissolve and absorb in the body. They used two sustainable materials—vaterite calcium carbonate crystals and biodegradable polymer microgels—to encapsulate CBD and improve its bioavailability. The vaterite crystals, which can be tuned to specific sizes ranging from 3-13 micrometers, successfully loaded up to 4% CBD by weight and can be easily customized by adjusting synthesis conditions like salt concentration and stirring speed. The polymer-coated microgels achieved approximately 1% CBD loading while demonstrating excellent stability in ethanol-water solutions.
These findings address a critical challenge in cannabis medicine: how to deliver poorly water-soluble cannabinoids more effectively to the body. Both carrier systems offer distinct advantages—vaterite crystals are inexpensive, non-toxic, and naturally degradable, while the multilayer microgels provide enhanced protection and controlled-release properties. By fine-tuning the size and composition of these carriers, researchers created a versatile platform that could dramatically improve CBD absorption and therapeutic effectiveness. This is particularly important for patients seeking CBD's documented benefits for pain, anxiety, and inflammation, as poor bioavailability currently limits its clinical potential.
The use of sustainable, biocompatible materials makes this approach environmentally responsible and scalable for commercial applications. Rather than relying on synthetic surfactants or organic solvents that may have safety concerns, these natural polymers and minerals provide a safer path toward more effective CBD products. The research demonstrates that smart material engineering can solve long-standing problems in cannabinoid delivery, opening doors for improved formulations across the cannabis industry.
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
Review describes AHC and reports cannabidiol as an additional treatment option
Review finds cannabidiol ineffective amid mixed dyspepsia treatment evidence
In mice, THC lowered observed seizure severity but caused marked sedation
Explore More Research
Stay informed about the latest cannabis science.